Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The Purpose of this study is to determine whether Adductor-Canal-Block is superior to placebo when it comes to analgetic efficacy after reconstruction of the anterior cruciate ligament.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Adductor-Canal-Block, Ropivacain | Experimental | 25 patients. ACB. 30 mL Ropivacain 7,5 mg/mL. Ultrasound-guided application. |
|
| Adductor Canal Block, Placebo (saline) | Placebo Comparator | 25 patients. ACB. 30 mL Saline. Ultrasound-guided application. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ropivacain | Procedure | Ultrasound-guided ACB; 30 mL Ropivacain 7,5 mg/mL. Single dose. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Pain-score (VAS), patient standing | Pain-score messured on a Visual Analog Scale (VAS) 2 hours after adductor canal block. Patient standing. Intervention-group vs. placebo-group. | 2 hours postoperative |
| Measure | Description | Time Frame |
|---|---|---|
| Total Opioid-consumption | ACB-group vs. placebo-group | 0-24 hours postoperative |
| Postoperative Nausea and Vomiting | Levels of nausea (0-3). ACB-group vs. placebo-group |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Malene Espelund, MD | Glostrup University Hospital, Copenhagen | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Anaesthesiology, Glostrup University Hospital | Copenhagen | Glostrup | 2600 | Denmark |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 23549123 | Derived | Espelund M, Fomsgaard JS, Haraszuk J, Mathiesen O, Dahl JB. Analgesic efficacy of ultrasound-guided adductor canal blockade after arthroscopic anterior cruciate ligament reconstruction: a randomised controlled trial. Eur J Anaesthesiol. 2013 Jul;30(7):422-8. doi: 10.1097/EJA.0b013e328360bdb9. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010146 | Pain |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D000077212 | Ropivacaine |
| D012965 | Sodium Chloride |
| ID | Term |
|---|---|
| D000813 | Anilides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D000814 | Aniline Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Saline | Procedure | Ultrasound-guided Adductor Canal Block; 30 mL Saline. Single dose. |
|
| 0 hour postoperative |
| Postoperative ondansetron consumption | In hospital |
| Pain-score (VAS), patient at rest | ACB-group vs. placebo | 0 hours postoperative |
| Pain-score (VAS), patient at rest | ACB-group vs. placebo | 1 hour postoperative |
| Pain-score (VAS), patient at rest | ACB-group vs. placebo | 2 hours postoperative |
| Pain-score (VAS), patient at rest | ACB-group vs. placebo | 4 hours postoperative |
| Pain-score (VAS), patient at rest | ACB-group vs. placebo | 6 hours postoperative |
| Pain-score (VAS), patient at rest | ACB-group vs. placebo | 8 hours postoperative |
| Pain-score (VAS), patient at rest | ACB-group vs. placebo | 24 hours postoperative |
| Pain-score (VAS), patient standing | ACB-group vs. placebo | 1 hour postoperative |
| Pain-score (VAS), patient standing | ACB-group vs. placebo | 2 hours postoperative |
| Pain-score (VAS), patient standing | ACB-group vs. placebo | 4 hours postoperative |
| Pain-score (VAS), patient standing | ACB-group vs. placebo | 6 hours postoperative |
| Pain-score (VAS), patient standing | ACB-group vs. placebo | 8 hours postoperative |
| Pain-score (VAS), patient standing | ACB-group vs. placebo | 24 hours postoperative |
| Pain-score (VAS), after 5 meters of walk | ACB-group vs. placebo | 2 hours postoperative |
| Pain-score (VAS), after 5 meters of walk | ACB-group vs. placebo | 4 hours postoperative |
| Pain-score (VAS), after 5 meters of walk | ACB-group vs. placebo | 6 hours postoperative |
| Pain-score (VAS), after 5 meters of walk | ACB-group vs. placebo | 8 hours postoperative |
| Pain-score (VAS), after 5 meters of walk | ACB-group vs. placebo | 24 hours postoperative |
| Postoperative Nausea and Vomiting | Levels of nausea (0-3). ACB-group vs. placebo-group | 1 hours postoperative |
| Postoperative Nausea and Vomiting | Levels of nausea (0-3). ACB-group vs. placebo-group | 2 hours postoperative |
| Postoperative Nausea and Vomiting | Levels of nausea (0-3). ACB-group vs. placebo-group | 4 hours postoperative |
| Postoperative Nausea and Vomiting | Levels of nausea (0-3). ACB-group vs. placebo-group | 6 hours postoperative |
| Postoperative Nausea and Vomiting | Levels of nausea (0-3). ACB-group vs. placebo-group | 8 hours postoperative |
| Postoperative Nausea and Vomiting | Levels of nausea (0-3). ACB-group vs. placebo-group | 24 hours postoperative |
| Sedation | Levels of sedation (0-3). ACB-group vs. placebo | 0, hour postoperative |
| Sedation | Levels of sedation (0-3). ACB-group vs. placebo | 1 hour postoperative |
| Sedation | Levels of sedation (0-3). ACB-group vs. placebo | 2 hours postoperative |
| Sedation | Levels of sedation (0-3). ACB-group vs. placebo | 4 hours postoperative |
| Sedation | Levels of sedation (0-3). ACB-group vs. placebo | 6 hours postoperative |
| Sedation | Levels of sedation (0-3). ACB-group vs. placebo | 8 hours postoperative |
| Sedation | Levels of sedation (0-3). ACB-group vs. placebo | 24 hours postoperative |
| Postoperative Nausea and Vomiting | Levels of nausea (0-3). ACB-group vs. placebo-group | 0 hours postoperative |
| Pain (VAS) at rest, 0-24 hours postoperative (AUC) | Pain-score messured on a Visual Analog Scale (VAS) 0-24 hours after adductor canal block (AUC). Patient at rest. Intervention-group vs. placebo-group. | 0-24 h postoperative |
| Pain (VAS), patient standing, 1-24 hours postoperative (AUC) | Pain-score messured on a Visual Analog Scale (VAS) 1-24 hours after adductor canal block (AUC). Patient standing. Intervention-group vs. placebo-group. | 1-24 hours postoperative |
| Pain (VAS), pain after 5 meters of walk, 2-24 hours postoperative (AUC) | Pain-score messured on a Visual Analog Scale (VAS) 2-24 hours after adductor canal block (AUC). Pain after 5 meters of walk. Intervention-group vs. placebo-group. | 2-24 hours postoperative |
| D000588 |
| Amines |
| D002712 | Chlorides |
| D006851 | Hydrochloric Acid |
| D017606 | Chlorine Compounds |
| D007287 | Inorganic Chemicals |
| D017670 | Sodium Compounds |